Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2017, Article ID 9480346, 9 pages
https://doi.org/10.1155/2017/9480346
Research Article

Metabolomics in COPD Acute Respiratory Failure Requiring Noninvasive Positive Pressure Ventilation

1Pulmonary, Department of Medicine, Critical Care and Occupational Medicine, University of Iowa Hospital and Clinics, Iowa City, IA, USA
2Critical Care and Acute Care Surgery Division, Department of Surgery, University of Minnesota, Minneapolis, MN, USA
3Pulmonary and Critical Care Division, Department of Medicine, University of Minnesota, Minneapolis, MN, USA

Correspondence should be addressed to Spyridon Fortis; ude.awoiu@sitrof-nodiryps

Received 20 July 2017; Revised 24 September 2017; Accepted 16 October 2017; Published 17 December 2017

Academic Editor: Frederik Trinkmann

Copyright © 2017 Spyridon Fortis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. CDC, “Chronic obstructive pulmonary disease among adults—United States, 2011,” Morbidity and Mortality Weekly Report, vol. 61, no. 46, pp. 938–943, 2012. View at Google Scholar
  2. K. Darnell, A. K. Dwivedi, Z. Weng, and R. J. Panos, “Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost,” Cost Effectiveness and Resource Allocation, vol. 11, no. 1, p. 13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. D. Sullivan, S. D. Ramsey, and T. A. Lee, “The economic burden of COPD,” Chest, vol. 117, no. 2, pp. 5S–9S, 2000. View at Publisher · View at Google Scholar
  4. S. A. Strassels, D. H. Smith, S. D. Sullivan, and P. S. Mahajan, “The costs of treating COPD in the United States,” Chest, vol. 119, no. 2, pp. 344–352, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. L. J. Nannini, “Hospitalization due to COPD exacerbation,” Chest, vol. 142, no. 6, p. 1697, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. F. Connors Jr., N. V. Dawson, C. Thomas et al., “Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments),” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 4, pp. 959–967, 1996. View at Publisher · View at Google Scholar
  7. J. Bourbeau, G. Ford, H. Zackon, N. Pinsky, J. Lee, and G. Ruberto, “Impact on patients’ health status following early identification of a COPD exacerbation,” European Respiratory Journal, vol. 30, no. 5, pp. 907–913, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. M. A. Wilkinson, G. C. Donaldson, J. R. Hurst, T. A. R. Seemungal, and J. A. Wedzicha, “Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 12, pp. 1298–1303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Bourbeau, M. F. Sedeno, K. Metz, P. Z. Li, and L. Pinto, “Early COPD exacerbation treatment with combination of ICS and LABA for patients presenting with mild-to-moderate worsening of dyspnea,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 13, no. 4, pp. 439–437, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Laue, E. Reierth, and H. Melbye, “When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines,” NPJ Primary Care Respiratory Medicine, vol. 25, no. 1, p. 15002, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Wang, Y. Tang, S. Liu et al., “Metabonomic profiling of serum and urine by 1H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals,” PLoS One, vol. 8, no. 6, p. e65675, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. B. K. Ubhi, J. H. Riley, P. A. Shaw et al., “Metabolic profiling detects biomarkers of protein degradation in COPD patients,” European Respiratory Journal, vol. 40, no. 2, pp. 345–355, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Gulcev, C. Reilly, T. J. Griffin et al., “Tryptophan catabolism in acute exacerbations of chronic obstructive pulmonary disease,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 11, pp. 2435–2446, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Fortis, C. Weinert, R. Bushinski, A. G. Koehler, and G. Beilman, “A health system-based critical care program with a novel tele-ICU: implementation, cost, and structure details,” Journal of the American College of Surgeons, vol. 219, no. 4, pp. 676–683, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. O. Beckonert, H. C. Keun, T. M. Ebbels et al., “Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts,” Nature Protocols, vol. 2, no. 11, pp. 2692–2703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. E. R. Lusczek, J. A. Paulo, J. R. Saltzman et al., “Urinary 1H-NMR metabolomics can distinguish pancreatitis patients from healthy controls,” JOP: Journal of the Pancreas, vol. 14, no. 2, pp. 161–170, 2013. View at Google Scholar
  17. TMIC, 2005, http://www.hmdb.ca/metabolites/HMDB00123.
  18. M. E. Suliman, A. R. Qureshi, P. Stenvinkel et al., “Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease,” American Journal of Clinical Nutrition, vol. 82, no. 2, pp. 342–349, 2005. View at Google Scholar
  19. M. D. Wheeler, K. Ikejema, N. Enomoto et al., “Glycine: a new anti-inflammatory immunonutrient,” Cellular and Molecular Life Sciences, vol. 56, no. 9-10, pp. 843–856, 1999. View at Publisher · View at Google Scholar
  20. TMIC, 2005, http://www.hmdb.ca/metabolites/hmdb00142.
  21. R. N. Feng, Y. C. Niu, X. W. Sun et al., “Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial,” Diabetologia, vol. 56, no. 5, pp. 985–994, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Watanabe, M. E. Suliman, A. R. Qureshi et al., “Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality,” American Journal of Clinical Nutrition, vol. 87, no. 6, pp. 1860–1866, 2008. View at Google Scholar
  23. L. C. Costello and R. B. Franklin, “‘Why do tumour cells glycolyse?’: from glycolysis through citrate to lipogenesis,” Molecular and Cellular Biochemistry, vol. 280, no. 1-2, pp. 1–8, 2005. View at Google Scholar
  24. J. M. Mates, J. A. Segura, J. A. Campos-Sandoval et al., “Glutamine homeostasis and mitochondrial dynamics,” The International Journal of Biochemistry & Cell Biology, vol. 41, no. 10, pp. 2051–2061, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. TMIC, 2005, http://www.hmdb.ca/metabolites/hmdb00162.
  26. V. M. Pinto-Plata, G. Livnat, M. Girish et al., “Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD,” Chest, vol. 131, no. 1, pp. 37–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Schutte, J. Lohmeyer, S. Rosseau et al., “Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema,” European Respiratory Journal, vol. 9, no. 9, pp. 1858–1867, 1996. View at Publisher · View at Google Scholar
  28. TMIC, 2005, http://www.hmdb.ca/metabolites/HMDB00439.
  29. S. S. Heinzmann, E. Holmes, S. Kochhar, J. K. Nicholson, and P. Schmitt-Kopplin, “2-furoylglycine as a candidate biomarker of coffee consumption,” Journal of Agricultural and Food Chemistry, vol. 63, no. 38, pp. 8615–8621, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. TMIC, 2005, http://www.hmdb.ca/metabolites/HMDB00750.